吉西他滨
医学
内科学
危险系数
紫杉醇
胰腺癌
临床终点
肿瘤科
无进展生存期
腺癌
临床研究阶段
化疗
胃肠病学
癌症
随机对照试验
置信区间
作者
Hani M. Babiker,Vincent J. Picozzi,Sreenivasa R Chandana,Bohuslav Melichar,Anup Kasi,Gang Jin,Javier Gallego,Andrea Bullock,Hao Chunyi,Lucjan Wyrwicz,Erika Hitre,Arsen Osipov,Christelle de la Fouchardière,Inmaculada Alés,Tomislav Dragovich,Woo‐Jin Lee,Kynan Feeney,Philip A. Philip,Makoto Ueno,Eric Van Cutsem
摘要
This study demonstrated significant OS, pain-free survival, and distant PFS benefits for TTFields with gemcitabine/nab-paclitaxel versus gemcitabine/nab-paclitaxel in patients with unresectable LA-PAC, with no additive systemic toxicity.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
Kao
无极微光
cdercder
乐空思
yjh123
kk
OK
Criminology34
GingerF
liuzhuohao
Nole
sagitar
keven
arniu2008
行走的荷尔蒙
小花
陶醉雪一
musen
YifanWang
皖公网安备34019202002308
